Investing in Agios Pharmaceuticals, Inc. (AGIO)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)10.49-64
Intrinsic value (DCF)6.77-77
Graham-Dodd Method0.00-100
Graham Formula0.00-100

Company description

Agios Pharmaceuticals, Inc. (AGIO) is a biopharmaceutical company that focuses on developing and commercializing transformative medicines for people with genetically defined diseases. Founded in 2008, Agios has made significant progress in its research and development efforts, leading to the approval of two FDA-approved medicines and a robust pipeline of potential treatments for various diseases. Their innovative approach to drug discovery and development centers around targeting specific metabolic pathways to address the underlying cause of diseases rather than just the symptoms. This unique strategy has led to partnerships with major pharmaceutical companies and recognition from the industry for their groundbreaking work. Agios continues to expand its pipeline and strive towards its mission of transforming the lives of patients through cutting-edge science and breakthrough medicines. With a strong leadership team and a dedicated workforce, Agios is well-positioned for future growth and success in the biopharmaceutical industry.